DPP-4
DPP-4 inhibitors are compounds that inhibit Dipeptidyl Peptidase-4, an enzyme involved in the inactivation of incretin hormones, which regulate glucose metabolism. By inhibiting DPP-4, these compounds help prolong the action of incretin hormones, enhancing insulin secretion and reducing blood glucose levels. DPP-4 inhibitors are widely used in the treatment of type 2 diabetes and in research focused on metabolic disorders. At CymitQuimica, we offer DPP-4 inhibitors to support your research in endocrinology, diabetes management, and metabolic disease.
Found 91 products for "DPP-4".
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
DBPR108
CAS:DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.Formula:C16H25FN4O2Purity:99.68%Color and Shape:SolidMolecular weight:324.39Ref: TM-T15079
1mg48.00€5mg100.00€1mL*10mM (DMSO)110.00€10mg133.00€25mg215.00€50mg306.00€100mg414.00€200mg573.00€Retagliptin Phosphate
CAS:Retagliptin Phosphate (SP 2086) is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.Formula:C19H21F6N4O7PPurity:98.70%Color and Shape:SolidMolecular weight:562.36Ref: TM-T12710
100mgTo inquire1mg34.00€2mg42.00€5mg60.00€1mL*10mM (DMSO)79.00€10mg87.00€25mg161.00€50mg245.00€Begelomab
CAS:Begelomab (SAND-26) is a mouse-derived monoclonal antibody targeting DPP-4/CD26. Begelomab can be used to study severe refractory inflammatory myopathies.Purity:97.8% (SDS-PAGE); 98.3% (SEC-HPLC) - 97.8% (SDS-PAGE); 98.3% (SEC-HPLC)Color and Shape:Transparent LiquidMolecular weight:146.20 kDa (Predicted)Denagliptin
CAS:Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine Ü metabolic diseases and can be used in the study ofFormula:C20H18F3N3OPurity:99.12%Color and Shape:SolidMolecular weight:373.37Trelagliptin
CAS:Trelagliptin (SYR-472) is a highly specific and long-acting DPP-4 inhibitor.Formula:C18H20FN5O2Purity:98.88%Color and Shape:SolidMolecular weight:357.38Saxagliptin hydrate
CAS:Saxagliptin hydrate (Onglyza hydrate) is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).Formula:C18H25N3O2·H2OPurity:99.52%Color and Shape:SolidMolecular weight:333.43AMG-222
CAS:AMG-222 (ALS-2-0426, ALS-20426) is a DPP-4 inhibitor and may be used in the treatment of type 2 diabetes.Formula:C32H39N9O3Color and Shape:SolidMolecular weight:597.71SGLT2-IN-5
SGLT2-IN-5 (Compound 99) is an orally active SGLT2 inhibitor with IC₅₀ values of 0.8 nM for SGLT2, 23 nM for SGLT1, and 58 nM for DPP4. In diabetic rat models, SGLT2-IN-5 effectively regulates blood glucose and increases the levels of active GLP-1. It is suitable for research on type 2 diabetes.Camegliptin
CAS:Cameglipti, a dipeptidyl peptidase IV (DPP-4) inhibitor, is used potentially for the treatment of type 2 diabetes.Formula:C20H28FN3O3Color and Shape:SolidMolecular weight:377.45Linagliptin Methyldimer
CAS:Linagliptin Methyldimer is a potent dipeptidyl peptidase IV inhibitor, IC50=6 pM.Formula:C50H56N16O4Purity:99.91%Color and Shape:SolidMolecular weight:945.08DPP-4/GPR119 modulator 1
CAS:Orally active DPP-4 inhibitor/GPR119 agonist, Compound 22 lowers glucose, moderate hERG inhibition, IC50 4.9 µM, for diabetes research.Formula:C30H39ClN10O3Color and Shape:SolidMolecular weight:623.15Sitagliptin fenilalanil hydrochloride
CAS:Sitagliptin fenilalanil hydrochloride is an orally active DPP-4 inhibitor. Sitagliptin fenilalanil hydrochloride is used in diabetes research.Formula:C25H25ClF6N6O2Purity:98.32%Color and Shape:White SolidMolecular weight:590.95Ellipyrone A
Ellipyrone A: γ-pyrone macrocycle, inhibits DPP-4 (IC50=0.35mM), α-glucosidase (IC50=0.74mM), α-amylase (IC50=0.59mM).Formula:C25H34O8Color and Shape:SolidMolecular weight:462.53Talabostat isomer mesylate
Talabostat isomer mesylate, a PT100/Val-boroPro variant, is a potent oral DPP-IV inhibitor (Ki: 0.18 nM).Formula:C10H23BN2O6SPurity:98%Color and Shape:SolidMolecular weight:310.18SGLT2-IN-6
SGLT2-IN-6 (Compound 101) is an orally active SGLT2 inhibitor with IC₅₀ values of 0.8 nM, 6.7 nM, and 72 nM for SGLT2, SGLT1, and DPP4, respectively. In diabetic rat models, SGLT2-IN-6 controls blood glucose levels and increases active GLP-1 levels. It is suitable for research on type 2 diabetes.Fotagliptin
CAS:Fotagliptin is a dipeptidyl peptidase IV inhibitor.Formula:C17H19FN6OColor and Shape:SolidMolecular weight:342.37HAEGT
CAS:HAEGT is the first N-terminal 1-5 residues of GLP-1 peptide.Formula:C20H31N7O9Purity:98%Color and Shape:SolidMolecular weight:513.5(-)-Sitagliptin Carbamoyl Glucuronide
CAS:Minor phase II metabolite of DPP-4 inhibitor sitagliptin, found in rat and dog plasma.Formula:C23H23F6N5O9Color and Shape:SolidMolecular weight:627.453Dutogliptin tartrate
CAS:Dutogliptin tartrate is an effective and selective oral dipeptide-peptide-4 (DPP4) inhibitor for the treatment of type 2 diabetes mellitus.Formula:C14H26BN3O9Purity:98%Color and Shape:SolidMolecular weight:391.18Fotagliptin benzoate
CAS:Fotagliptin benzoate, a DPP-4 inhibitor (IC50=2.27 nM), is safe in rats/dogs, useful for Type 2 diabetes research.Formula:C24H25FN6O3Color and Shape:SolidMolecular weight:464.49
